## Abstract A new generation combination test (Detect‐Plus, IAF BioChem, Montreal, Canada) based on synthetic peptides for HIV‐1, HIV‐2, HTLV‐I, and HTLV‐II was compared with three routine commercial screening assays and confirmatory assays to determine its sensitivity and specificity and to evalua
A recombinant protein based immunoassay for the combined detection of antibodies to HIV-1, HIV-2 and HTLV-I
✍ Scribed by Jesús Benı́tez; Daniel Palenzuela; Juan Rivero; Jorge V. Gavilondo
- Book ID
- 114140482
- Publisher
- Elsevier Science
- Year
- 1998
- Tongue
- English
- Weight
- 109 KB
- Volume
- 70
- Category
- Article
- ISSN
- 0166-0934
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Background Availability of accurate diagnostic tests has been helpful in curtailing the spread of HIV infection. Among these, simple, point of care, inexpensive tests which require only a drop of blood from finger-prick and give reliable results within minutes are a must for expansion of testing
Recombinant HIV-1 p17 antigen (rp17) and maltose binding protein-rp17 fusion protein (MBP-rp17) were immobilized in different ways: rp17 and MBP-rp17 were immobilized directly onto polystyrene beads by physical adsorption, and biotinyl-rp17, biotinyl-MBP-rp17, and 2,4-dinitrophenyl (DNP)-MBP-rp17 we